about
Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.Asparagine synthetase chemotherapy.Protein biomarkers distinguish between high- and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner.The concurrent occurrence of Leishmania chagasi infection and childhood acute leukemia in BrazilXenograft models for the preclinical evaluation of new therapies in acute leukemia.Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinomaResults of treatment of advanced-stage lymphoblastic lymphoma at St Jude Children's Research Hospital from 1962 to 2002Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cells.Down-regulation of asparagine synthetase induces cell cycle arrest and inhibits cell proliferation of breast cancer.Prediction of immunophenotype, treatment response, and relapse in childhood acute lymphoblastic leukemia using DNA microarrays.Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children.Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia
P2860
Q33744912-BD6C215B-4BBA-42CF-97D9-982B135C9FA8Q34535185-58549E08-8197-4AAC-B857-DED9A75C0041Q34816101-2FB5FB66-3582-48EA-9D34-E54828D4AB55Q35053310-3C7452A2-37EB-46ED-9B29-2120EE124317Q36799846-8528CD9D-56FE-438C-9835-F524D750A565Q37003403-979EA7B5-628C-44F4-B3C4-98A024DCA29DQ37126934-CBEBF51A-77A4-4480-B98C-1130A597A893Q38298331-14B4F02C-8235-4BD3-BE1C-07528D111E57Q38767064-CE91BA40-7FA0-4963-B782-7D1BC5FD6CE6Q39000725-A7839321-A3D4-49F0-A137-3EBD706ED17FQ43514458-CE8BAF77-F652-44B6-B72A-D12461A62993Q48337182-128E551E-7B09-4864-81DC-84D77F919D20Q50662692-5B6D7A9D-AA5D-482D-A5FE-85F31093324CQ59194346-76E1943F-9823-4782-B82C-BA117676EC90
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Childhood acute lymphoblastic leukemia.
@en
type
label
Childhood acute lymphoblastic leukemia.
@en
prefLabel
Childhood acute lymphoblastic leukemia.
@en
P2093
P2860
P1476
Childhood acute lymphoblastic leukemia.
@en
P2093
Dario Campana
Mary V Relling
William E Evans
P2860
P304
161-80; discussion 200-2
P356
10.1046/J.1468-0734.2002.00067.X
P577
2002-06-01T00:00:00Z